DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
200 hedge funds and large institutions have $960M invested in DIPLOMAT PHARMACY, INC. in 2017 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 69 increasing their positions, 51 reducing their positions, and 20 closing their positions.
180% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 20
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
35% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 51
21% more funds holding
Funds holding: 165 → 200 (+35)
7% less capital invested
Capital invested by funds: $1.03B → $960M (-$71.4M)
30% less call options, than puts
Call options by funds: $2.36M | Put options by funds: $3.39M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
+$14.1M |
| 2 |
JP Morgan Chase
New York
|
+$8.98M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.23M |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$7.67M |
| 5 |
Morgan Stanley
New York
|
+$5.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
Hermes Investment Management
London Uk,
United Kingdom
|
-$28.2M |
| 2 |
Millennium Management
New York
|
-$26.2M |
| 3 |
ClearBridge Investments
New York
|
-$25.7M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$19.8M |
| 5 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
-$16.6M |
DPLO Hedge Fund Activity: Q4 2017 in Review
200 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2017, worth a combined $960M — down 6.9% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new DPLO positions and 20 closed out — a net gain of 36 holders — while 69 added to existing stakes and 51 trimmed.
The largest buyer was Fort Washington Investment Advisors, opening a new position worth an estimated $14.1M. The largest seller was Hermes Investment Management, exiting entirely with an estimated $28.2M sold.
- 200 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2017, up from 165 in Q3 2017.
- Funds reported $960M of DIPLOMAT PHARMACY, INC. stock for Q4 2017, down 6.9% quarter-over-quarter.
- 56 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2017 and 20 closed out, a net change of +36 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2017 was Fort Washington Investment Advisors, an estimated $14.1M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q4 2017 was Hermes Investment Management, an estimated $28.2M sold.
Based on aggregated 13F filings for Q4 2017.